General AML

Kristoffer Hellstrand | ISAL 2019 | Immunotherapy with histamine dihydrochloride and IL-2 in AML

L:

ACUTE LEUKEMIAS XVII Biology and Treatment Strategies, February 24–27 2019, Munich, DE

Kristoffer Hellstrand

Sahlgrenska Cancer Center, Gothenburg, SE

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF
Was this article informative? Thank you for your feedback!